Compare
Exousia Bio, Inc. vs Graham Holdings Co vs Covista Inc. vs Laureate Education, Inc.
| Latest fiscal year | Exousia Bio, Inc. LMMYRevenue covers only part of its income (partial revenue) | Graham Holdings Co GHC | Covista Inc. CVSA | Laureate Education, Inc. LAUR |
|---|---|---|---|---|
| Year ended | 2025-05-31 | 2025-12-31 | 2026-06-30 | 2025-12-31 |
| Revenue | n/a | $4.91B | $1.95B | $1.70B |
| Revenue growth (YoY) | n/a | +2.5% | +9.3% | +8.6% |
| Gross margin | n/a | n/a | 57.3% (computed) | 28.3% (computed) |
| Operating margin | n/a | 4.8% | 19.6% | 25.3% |
| Net margin | n/a | 6.0% | 12.9% | 16.5% |
| Net income | $51.4K | $292.29M | $251.57M | $281.63M |
| EPS (Diluted) | $0.00 | $66.47 | $7.04 | $1.89 |
| Operating cash flow | -$4.5K | $347.19M | $470.42M | $366.19M |
| Free cash flow | n/a | $275.30M | $392.73M | $263.15M |
| Cash & equivalents | n/a | $266.99M | $406.32M | $146.70M |
| Total assets | $0 | $8.40B | $3.01B | $2.21B |
| Total liabilities | $0 | $3.53B | $1.57B | $1.02B |
| Shareholders' equity | $0 | $4.83B | $1.45B | $1.19B |
| Return on year-end equity | n/a | 6.1% | 17.4% | 23.7% |
| Shares outstanding | 7.78M | n/a | 34.03M | 142.94M |
Revenue, most recent five fiscal years
| Fiscal year | Exousia Bio, Inc. | Graham Holdings Co | Covista Inc. | Laureate Education, Inc. |
|---|---|---|---|---|
| Latest | n/a | $4.91B Ended 2025-12-31 | $1.95B Ended 2026-06-30 | $1.70B Ended 2025-12-31 |
| 1 year earlier | n/a | $4.79B Ended 2024-12-31 | $1.79B Ended 2025-06-30 | $1.57B Ended 2024-12-31 |
| 2 years earlier | n/a | $4.41B Ended 2023-12-31 | $1.58B Ended 2024-06-30 | $1.48B Ended 2023-12-31 |
| 3 years earlier | n/a | $3.92B Ended 2022-12-31 | $1.45B Ended 2023-06-30 | $1.24B Ended 2022-12-31 |
| 4 years earlier | n/a | $3.19B Ended 2021-12-31 | $1.38B Ended 2022-06-30 | $1.09B Ended 2021-12-31 |